BR112017021619A2 - hemostato compósito integrado na forma de tecido não tecido, e, método para preparar hemostato compósito integrado na forma de tecido não tecido. - Google Patents

hemostato compósito integrado na forma de tecido não tecido, e, método para preparar hemostato compósito integrado na forma de tecido não tecido.

Info

Publication number
BR112017021619A2
BR112017021619A2 BR112017021619-1A BR112017021619A BR112017021619A2 BR 112017021619 A2 BR112017021619 A2 BR 112017021619A2 BR 112017021619 A BR112017021619 A BR 112017021619A BR 112017021619 A2 BR112017021619 A2 BR 112017021619A2
Authority
BR
Brazil
Prior art keywords
integrated
woven fabric
composite hemostat
hemostat
composite
Prior art date
Application number
BR112017021619-1A
Other languages
English (en)
Inventor
Kyoon Kim Hyun
su kim Jin
Sung Yoon Hye
Bae Kim Jun
Dong Yeo Guw
Original Assignee
Samyang Biopharmaceuticals Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals Corporation filed Critical Samyang Biopharmaceuticals Corporation
Publication of BR112017021619A2 publication Critical patent/BR112017021619A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Abstract

é proporcionado um agente hemostático compósito de tipo de tecido não tecido, obtido por sobreposição de (i) pelo menos uma folha contínua de um primeiro polímero selecionado do grupo que consiste em polímeros biodegradáveis, celulose de regeneração oxidativa e neutralizadores de sal de metal alcalino de celulose de regeneração oxidativa e (ii) pelo menos uma folha contínua de um segundo polímero selecionado do grupo que consiste em celulose de regeneração oxidativa e neutralizadores de sal de metal alcalino, seguidos de perfuração com agulha, compressão e integração.
BR112017021619-1A 2015-04-15 2016-04-14 hemostato compósito integrado na forma de tecido não tecido, e, método para preparar hemostato compósito integrado na forma de tecido não tecido. BR112017021619A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020150053041A KR101878774B1 (ko) 2015-04-15 2015-04-15 다기능성 지혈제 및 그 제조 방법
KR10-2015-0053041 2015-04-15
PCT/KR2016/003872 WO2016167560A1 (ko) 2015-04-15 2016-04-14 다기능성 지혈제 및 그 제조 방법

Publications (1)

Publication Number Publication Date
BR112017021619A2 true BR112017021619A2 (pt) 2018-07-03

Family

ID=57126290

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017021619-1A BR112017021619A2 (pt) 2015-04-15 2016-04-14 hemostato compósito integrado na forma de tecido não tecido, e, método para preparar hemostato compósito integrado na forma de tecido não tecido.

Country Status (6)

Country Link
US (1) US20180036414A1 (pt)
EP (1) EP3284461A4 (pt)
KR (1) KR101878774B1 (pt)
CN (1) CN107580494A (pt)
BR (1) BR112017021619A2 (pt)
WO (1) WO2016167560A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018105918A2 (ko) * 2016-12-05 2018-06-14 주식회사 삼양바이오팜 섬유 웹, 피브릴상 섬유 또는 부직포를 제조하는 방법 및 그에 의하여 제조된 섬유 웹, 피브릴상 섬유 또는 부직포
KR102145097B1 (ko) * 2017-07-05 2020-08-14 가톨릭대학교 산학협력단 지혈가능 트롬빈 결합 생분해성 plga 메쉬 및 이의 제조방법
KR20200135018A (ko) * 2019-05-24 2020-12-02 주식회사 삼양바이오팜 섬유 웹, 피브릴상 섬유 집합체 또는 부직포를 제조하기 위한 장치 및 방법, 및 그에 의하여 제조된 섬유 웹, 피브릴상 섬유 집합체 또는 부직포
IL268572A (en) * 2019-08-07 2019-09-26 Omrix Biopharmaceuticals Ltd An expandable hemostatic composed of oxidized cellulose

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840626A (en) * 1986-09-29 1989-06-20 Johnson & Johnson Patient Care, Inc. Heparin-containing adhesion prevention barrier and process
US5134229A (en) * 1990-01-12 1992-07-28 Johnson & Johnson Medical, Inc. Process for preparing a neutralized oxidized cellulose product and its method of use
CZ288792B6 (cs) * 1993-12-23 2001-09-12 Johnson & Johnson Medical, Inc. Bioabsorbovatelný chirurgický hemostat a způsob jeho výroby
FR2783429B1 (fr) * 1998-09-18 2002-04-12 Imedex Biomateriaux Materiau collagenique bicomposite,son procede d'obtention et ses applications therapeutiques
KR100316200B1 (ko) * 1999-04-22 2001-12-12 김정식 외과수술용 유착방지제(外科手術用 癒着防止劑)
US20040101548A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Hemostatic wound dressing containing aldehyde-modified polysaccharide
US20060258995A1 (en) * 2004-10-20 2006-11-16 Pendharkar Sanyog M Method for making a reinforced absorbable multilayered fabric for use in medical devices
EP2052746B1 (en) * 2004-10-20 2014-11-26 Ethicon, Inc. Absorbable hemostat
CN101084022A (zh) * 2004-10-20 2007-12-05 伊西康公司 可吸收的止血物
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
KR20130060276A (ko) * 2004-10-20 2013-06-07 에디컨인코포레이티드 의료 장치에 사용하기 위한 강화 흡수성 다층 직물 및 이의 제조방법
US20060155235A1 (en) * 2004-12-17 2006-07-13 Sawyer Evelyn S Hemostatic compression bandage
CA2649081A1 (en) * 2006-04-10 2007-10-18 Ethicon, Inc. A reinforced absorbable multilayered hemostatic wound dressing and method of making
CA2756386C (en) * 2009-03-23 2019-01-15 Micell Technologies, Inc. Drug delivery medical device
CN101890179A (zh) * 2009-05-18 2010-11-24 惠州华阳医疗器械有限公司 一种可降解吸收的水溶性止血材料及其制备方法
US8349354B2 (en) * 2009-09-22 2013-01-08 Ethicon, Inc. Composite layered hemostasis device
KR101070358B1 (ko) * 2009-12-24 2011-10-05 한국생산기술연구원 의료용 부직포 및 그의 제조방법
US8329211B2 (en) * 2010-05-17 2012-12-11 Ethicon, Inc. Reinforced absorbable multi-layered fabric for hemostatic applications
US8273369B2 (en) * 2010-05-17 2012-09-25 Ethicon, Inc. Reinforced absorbable synthetic matrix for hemostatic applications
US20130084324A1 (en) * 2011-09-30 2013-04-04 Michel Gensini Adhesion prevention fabric
JP2013135704A (ja) * 2011-12-28 2013-07-11 Hogi Medical:Kk 止血材及びその製造方法
KR101624625B1 (ko) * 2012-12-28 2016-05-26 주식회사 삼양바이오팜 개선된 흡수성 지혈제 및 그 제조방법

Also Published As

Publication number Publication date
EP3284461A1 (en) 2018-02-21
WO2016167560A1 (ko) 2016-10-20
KR20160123422A (ko) 2016-10-26
CN107580494A (zh) 2018-01-12
EP3284461A4 (en) 2018-12-26
KR101878774B1 (ko) 2018-07-17
US20180036414A1 (en) 2018-02-08

Similar Documents

Publication Publication Date Title
BR112017021619A2 (pt) hemostato compósito integrado na forma de tecido não tecido, e, método para preparar hemostato compósito integrado na forma de tecido não tecido.
BR112017001140A2 (pt) composição de poliolefina heterofásica modificada
CO6700875A2 (es) Tela no tejida, su método de fabricación y filtros formados por la misma
UY35248A (es) ?caco3 en poliéster para telas no tejidas y fibras?.
BR112016023646A2 (pt) fibras e artigos as que incluem
BR112017023560A2 (pt) composição de polímero reforçada com fibra, e, artigo.
BR112018000662A2 (pt) ?compósito não tecido hidroentrelaçado imageado com baixo desprendimento de fiapo?
BR112017023516A2 (pt) composição de polímero reforçado com fibra, e, artigo.
CL2014002046A1 (es) Placa de yeso que tiene un nucleo con por lo menos un lado cubierto por una tela no tejida adecuada para áreas mojadas o húmedas.
BR112013004279A2 (pt) trama não tecida e fibras com propriedades de eletreto, processos de fabricação das mesmas e seu uso
BR112017000166A2 (pt) composição de polipropileno, fibras sopradas em fusão, tela soprada em fusão, artigo, e, uso de uma composição de polipropileno
BR112019008230A2 (pt) compostos de polímero de liberação de sulfeto de hidrogênio
BR112017014938A2 (pt) material de aquisição não-tecido em múltiplas camadas, material não-tecido em múltiplas camadas e compósito absorvente
BR112018003864A2 (pt) método para preparação de uma composição de ácido hialurônico, composição, e, método para restauração de um tecido
BR112016002180A2 (pt) composição amaciante de tecido, método para tratamento de tecido e uso de uma composição
BR112017000775A2 (pt) ligante para briquete de carvão para preparar briquete de carvão
MX2018006109A (es) Un material absorbente.
MX2017014464A (es) Composicion reticulante que incluye silicato sintetico en capas.
BR112013007740A2 (pt) métodos para processamento de microesferas, microesferas processadas por tais métodos e seus usos
BR112017008066A2 (pt) composição de polipropileno, processo para produção da composição de polipropileno, e, espuma extrusada.
BR112015023342A2 (pt) resinas acopladas radicalmente e métodos para preparar e usar as mesmas
BR102012023966B8 (pt) método para preparar uma celulose carboxilada fibrosa estável
IL250881A0 (en) A process of instant creation of artificial bone tissue
BR112017019207A2 (pt) recuperação e/ou reutilização de catalisador de paládio após acoplamento de suzuki
AR093689A1 (es) Una composicion para la preparacion de acido hialuronico reticulado viscoelastico, y acido hialuronico reticulado obtenido al usar la misma

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: SAMYANG HOLDINGS CORPORATION (KR)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2718 DE 07-02-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.